Financials Tejnaksh Healthcare Limited
Equities
TEJNAKSH6
INE030T01027
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.23 INR | +0.91% | -0.77% | -19.20% |
Valuation
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 938.4 | 564.7 | 365.6 | 739.4 | 1,711 | 699.9 |
Enterprise Value (EV) 1 | 996.4 | 615.6 | 424.6 | 776 | 1,751 | 732.8 |
P/E ratio | 32.3 x | 18.7 x | 17.5 x | 36 x | 62.8 x | 41.6 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 6.32 x | 2.65 x | 2.11 x | 6.14 x | 13.5 x | 5.9 x |
EV / Revenue | 6.71 x | 2.89 x | 2.45 x | 6.44 x | 13.8 x | 6.17 x |
EV / EBITDA | 17.4 x | 10.8 x | 9.93 x | 20.4 x | 36.8 x | 19.3 x |
EV / FCF | -492 x | 249 x | -30.5 x | 15.9 x | -28.6 x | 196 x |
FCF Yield | -0.2% | 0.4% | -3.27% | 6.31% | -3.5% | 0.51% |
Price to Book | 8.56 x | 4.29 x | 2.4 x | 4.27 x | 8.53 x | 3.22 x |
Nbr of stocks (in thousands) | 20,314 | 20,314 | 20,314 | 20,314 | 20,314 | 20,314 |
Reference price 2 | 46.20 | 27.80 | 18.00 | 36.40 | 84.25 | 34.46 |
Announcement Date | 10/7/18 | 9/4/19 | 9/5/20 | 9/2/21 | 9/1/22 | 8/30/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 148.4 | 212.9 | 173.6 | 120.4 | 126.8 | 118.7 |
EBITDA 1 | 57.27 | 57.14 | 42.78 | 37.95 | 47.62 | 38.07 |
EBIT 1 | 52.62 | 51.27 | 36.3 | 31.2 | 41.33 | 29.55 |
Operating Margin | 35.46% | 24.08% | 20.91% | 25.91% | 32.6% | 24.9% |
Earnings before Tax (EBT) 1 | 40.17 | 43.64 | 29.66 | 26.68 | 37.61 | 25.13 |
Net income 1 | 29.01 | 30.25 | 20.9 | 20.53 | 27.24 | 16.83 |
Net margin | 19.55% | 14.21% | 12.04% | 17.05% | 21.49% | 14.18% |
EPS 2 | 1.428 | 1.489 | 1.029 | 1.011 | 1.341 | 0.8283 |
Free Cash Flow 1 | -2.025 | 2.475 | -13.9 | 48.96 | -61.29 | 3.732 |
FCF margin | -1.36% | 1.16% | -8.01% | 40.65% | -48.35% | 3.14% |
FCF Conversion (EBITDA) | - | 4.33% | - | 129% | - | 9.8% |
FCF Conversion (Net income) | - | 8.18% | - | 238.47% | - | 22.18% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 10/7/18 | 9/4/19 | 9/5/20 | 9/2/21 | 9/1/22 | 8/30/23 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 58 | 50.9 | 59 | 36.6 | 40 | 32.9 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.012 x | 0.8903 x | 1.378 x | 0.9643 x | 0.8396 x | 0.8638 x |
Free Cash Flow 1 | -2.02 | 2.48 | -13.9 | 49 | -61.3 | 3.73 |
ROE (net income / shareholders' equity) | 29.6% | 26.2% | 14.7% | 12.4% | 14.7% | 8.33% |
ROA (Net income/ Total Assets) | 18.3% | 15.2% | 9.62% | 7.88% | 9.53% | 6.07% |
Assets 1 | 158.7 | 198.4 | 217.3 | 260.5 | 285.7 | 277.1 |
Book Value Per Share 2 | 5.400 | 6.480 | 7.510 | 8.520 | 9.870 | 10.70 |
Cash Flow per Share 2 | 0.8600 | 0.6100 | 0.6400 | 0.6100 | 0.7200 | 0.4900 |
Capex 1 | 12 | 11.7 | 10.8 | 4.43 | 90.8 | 8.26 |
Capex / Sales | 8.07% | 5.51% | 6.22% | 3.68% | 71.61% | 6.96% |
Announcement Date | 10/7/18 | 9/4/19 | 9/5/20 | 9/2/21 | 9/1/22 | 8/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-19.20% | 5.6M | |
+16.82% | 82.82B | |
-27.95% | 71.42B | |
-0.28% | 26.41B | |
+2.67% | 17.73B | |
-10.70% | 17.11B | |
+0.75% | 15.43B | |
+74.84% | 13.45B | |
-25.61% | 12.86B | |
+71.06% | 12.63B |
- Stock Market
- Equities
- TEJNAKSH6 Stock
- Financials Tejnaksh Healthcare Limited